English
Regional settings| Spread | 0.40 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 35.91 |
| Open | 35.07 |
| 1-Year Change | 127.88% |
| Day's Range | 34.49 - 36.14 |
Kewaunee Scientific Corporation is engaged in the designing, manufacturing, and installation of laboratory, healthcare, technical furniture and infrastructure products. The Company operates through two segments: Domestic, and International. The Company's Domestic business segment is engaged in designing, manufacturing, and installing scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, worksurfaces, workstations, workbenches and computer enclosures. Its International business segment consists of foreign subsidiaries, such as Kewaunee Labway Asia Pte. Ltd., Kewaunee Scientific Corporation Singapore Pte. Ltd., Kewaunee Labway India Pvt. Ltd., and Koncepo Scientech International Pvt. Ltd., which provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.
BRIEF: For the nine months ended 31 January 2022, Kewaunee Scientific Corporation revenues increased 10% to $119.2M. Net loss increased from $697K to $5.8M. Revenues reflect Domestic segment increase of 6% to $89.1M, International segment increase of 21% to $30M, Domestic segment increase of 6% to $89.1M, International segment increase of 21% to $30M. Higher net loss reflects Operating expenses increase of 6% to $19.7M (expense).
Common Stock $2.50 Par, 03/11, 5M auth., 2,578,270 o/s., net of shs. in Treas. @ Cost. Insiders & Strategic holders own 29.66%. Public Offering 2/68, 286,000 shares @ $25 by Glore Forgan & Wm.R. Stats.
